ATE444751T1 - Behandlung von psychosen oder neuropsychiatrischen störungen im zusammenhang mit alzheimer - Google Patents

Behandlung von psychosen oder neuropsychiatrischen störungen im zusammenhang mit alzheimer

Info

Publication number: ATE444751T1
Authority: AT; Austria
Prior art keywords: treatment; psychoses; alzheimer; disorders related; neuropsychiatric disorders
Prior art date: 1998-07-15

Application number

AT99937263T

Other languages

English (en)

Inventor

Eve Cedar

James Mccafferty

Original Assignee

Minster Pharmaceuticals Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-07-15

Filing date

1999-07-15

Publication date

2009-10-15

1999-07-15 Application filed by Minster Pharmaceuticals Plc filed Critical Minster Pharmaceuticals Plc

2009-10-15 Application granted granted Critical

2009-10-15 Publication of ATE444751T1 publication Critical patent/ATE444751T1/de

Links

208000028017 Psychotic disease Diseases 0.000 title abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 abstract 3
150000003839 salts Chemical class 0.000 abstract 1
208000024891 symptom Diseases 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/439—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Chemical Treatment Of Metals (AREA)
Liquid Crystal Substances (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Liquid Crystal (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Electrical Discharge Machining, Electrochemical Machining, And Combined Machining (AREA)
Saccharide Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

AT99937263T 1998-07-15 1999-07-15 Behandlung von psychosen oder neuropsychiatrischen störungen im zusammenhang mit alzheimer ATE444751T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB9815383.6A GB9815383D0 (en)	1998-07-15	1998-07-15	Novel method of treatment
PCT/US1999/016002 WO2000003717A1 (en)	1998-07-15	1999-07-15	Method of treatment

Publications (1)

Publication Number	Publication Date
ATE444751T1 true ATE444751T1 (de)	2009-10-15

Family

ID=10835581

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT99937263T ATE444751T1 (de)	1998-07-15	1999-07-15	Behandlung von psychosen oder neuropsychiatrischen störungen im zusammenhang mit alzheimer

Country Status (20)

Country	Link
US (2)	US20020156093A1 (de)
EP (1)	EP1104301B1 (de)
JP (1)	JP2002520364A (de)
KR (1)	KR20010071893A (de)
CN (1)	CN1146420C (de)
AT (1)	ATE444751T1 (de)
AU (1)	AU758936B2 (de)
BR (1)	BR9912008A (de)
CA (1)	CA2337229A1 (de)
CZ (1)	CZ2001150A3 (de)
DE (1)	DE69941509D1 (de)
GB (1)	GB9815383D0 (de)
HU (1)	HUP0103149A3 (de)
IL (1)	IL140629A0 (de)
NO (1)	NO20010195L (de)
NZ (1)	NZ509177A (de)
PL (1)	PL345505A1 (de)
TR (1)	TR200100088T2 (de)
WO (1)	WO2000003717A1 (de)
ZA (1)	ZA200100360B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB0008921D0 (en) *	2000-04-11	2000-05-31	Smithkline Beecham Plc	Method of treatment
KR100971395B1 (ko) *	2003-07-23	2010-07-21	엘지디스플레이 주식회사	백 라이트 유닛
JP4792726B2 (ja) *	2003-10-30	2011-10-12	日亜化学工業株式会社	半導体素子用支持体の製造方法
GB0428170D0 (en) *	2004-12-23	2005-01-26	Biopartners Ltd	Mono and Combination Therapy

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SG48315A1 (en) *	1989-04-13	1998-04-17	Beecham Group Plc	Novel compounds
GB9421472D0 (en) *	1994-10-25	1994-12-07	Smithkline Beecham Plc	Novel methods
GB9615628D0 (en) *	1996-07-25	1996-09-04	Smithkline Beecham Plc	Formulation
AU5716898A (en) *	1997-01-08	1998-08-03	Warner-Lambert Company	Acetylcholinesterase inhibitors in combination with muscarinic agonists for the treatment of alzheimer's disease
EP1009403A4 (de)	1997-04-11	2002-08-28	Lilly Co Eli	Verfahren zur behandlung von schizophrenie

1998
- 1998-07-15 GB GBGB9815383.6A patent/GB9815383D0/en not_active Ceased
1999
- 1999-07-15 IL IL14062999A patent/IL140629A0/xx unknown
- 1999-07-15 DE DE69941509T patent/DE69941509D1/de not_active Expired - Lifetime
- 1999-07-15 CN CNB998086045A patent/CN1146420C/zh not_active Expired - Fee Related
- 1999-07-15 CA CA002337229A patent/CA2337229A1/en not_active Abandoned
- 1999-07-15 HU HU0103149A patent/HUP0103149A3/hu unknown
- 1999-07-15 AT AT99937263T patent/ATE444751T1/de not_active IP Right Cessation
- 1999-07-15 WO PCT/US1999/016002 patent/WO2000003717A1/en not_active Ceased
- 1999-07-15 NZ NZ509177A patent/NZ509177A/en unknown
- 1999-07-15 PL PL99345505A patent/PL345505A1/xx not_active Application Discontinuation
- 1999-07-15 TR TR2001/00088T patent/TR200100088T2/xx unknown
- 1999-07-15 BR BR9912008-9A patent/BR9912008A/pt not_active IP Right Cessation
- 1999-07-15 JP JP2000559852A patent/JP2002520364A/ja not_active Withdrawn
- 1999-07-15 AU AU52137/99A patent/AU758936B2/en not_active Ceased
- 1999-07-15 CZ CZ2001150A patent/CZ2001150A3/cs unknown
- 1999-07-15 EP EP99937263A patent/EP1104301B1/de not_active Expired - Lifetime
- 1999-07-15 KR KR1020017000561A patent/KR20010071893A/ko not_active Withdrawn
2001
- 2001-01-12 ZA ZA200100360A patent/ZA200100360B/en unknown
- 2001-01-12 NO NO20010195A patent/NO20010195L/no not_active Application Discontinuation
2002
- 2002-04-17 US US10/124,707 patent/US20020156093A1/en not_active Abandoned
2003
- 2003-02-21 US US10/372,577 patent/US6750227B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
GB9815383D0 (en)	1998-09-16
EP1104301B1 (de)	2009-10-07
BR9912008A (pt)	2001-04-10
CA2337229A1 (en)	2000-01-27
CZ2001150A3 (cs)	2001-09-12
KR20010071893A (ko)	2001-07-31
DE69941509D1 (de)	2009-11-19
AU5213799A (en)	2000-02-07
HUP0103149A2 (hu)	2002-01-28
NO20010195D0 (no)	2001-01-12
AU758936B2 (en)	2003-04-03
US20020156093A1 (en)	2002-10-24
IL140629A0 (en)	2002-02-10
EP1104301A4 (de)	2004-09-15
ZA200100360B (en)	2002-03-12
CN1146420C (zh)	2004-04-21
CN1309564A (zh)	2001-08-22
PL345505A1 (en)	2001-12-17
NZ509177A (en)	2003-05-30
US6750227B2 (en)	2004-06-15
JP2002520364A (ja)	2002-07-09
EP1104301A1 (de)	2001-06-06
TR200100088T2 (tr)	2001-06-21
WO2000003717A1 (en)	2000-01-27
HUP0103149A3 (en)	2003-03-28
US20030125353A1 (en)	2003-07-03
NO20010195L (no)	2001-01-12

Similar Documents

Publication	Publication Date	Title
MY130145A (en)	2007-06-29	Quinuclidine derivative for treatment of inflammatory and gastrointestinal disorders.
NZ332780A (en)	2000-07-28	Substituted amines for the treatment of neurological and neuropsychiatric disorders
MY103352A (en)	1993-06-30	Piperazinyl-heterocyclic compounds
MY107157A (en)	1995-09-30	Quinuclidine derivatives.
GB9406857D0 (en)	1994-06-01	Improvements in or relating to organic compounds
IL101960A0 (en)	1994-04-12	Substituted 3-aminoquininuclidines
IN172468B (de)	1993-08-14
GR3035957T3 (en)	2001-08-31	Use of riluzole for treating aids-related neural disorders
CA2260145A1 (en)	1998-01-15	Use of l-acetylcarnitine, l-isovalerylcarnitine, l-propionylcarnitine for increasing the levels of igf-1
FI911083A7 (fi)	1991-09-07	Menetelmä kolinergisina aineina käyttökelpoisten 1-atsabisyklo/2.2.1/heptaani- tai -/2.2.2/oktaani-3-oni-O-oksiimien valmistamiseksi
DK599789D0 (da)	1989-11-28	3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler
BG102589A (en)	1999-09-30	3-azetidinylalkylpiperidines or -pyrrolidines as tachykin antagonists
GR3032122T3 (en)	2000-04-27	Novel 2,9-disubstituted-4H-pyrido-[1,2-a]pyrimidin-4-ones.
ATE186908T1 (de)	1999-12-15	1,2,3,4-tetrahydro-9-akridinamine-derivate
ES2096413T3 (es)	1997-03-01	Derivado de acido 5-amino-8-metil-7-pirrolidinilquinoleina-3-carboxilico.
SG48415A1 (en)	1998-04-17	Process for the purification of a 3-cephem-4-carboxylic acid derivative
DE69941509D1 (de)	2009-11-19	Behandlung von Psychosen oder neuropsychiatrischen Störungen im Zusammenhang mit Alzheimer
EA200000242A1 (ru)	2000-08-28	Применение фанхинона для лечения болезни альцгеймера
IT1274997B (it)	1997-07-29	Procedimento per la produzione di spazzole nonche' macchina per la produzione di spazzole per l'esecuzione del procedimento
HU9201247D0 (en)	1992-07-28	Process for the production of condensed diazepinone derivatives and of mnedical preparations containing them as active agents
TR199900141T2 (xx)	1999-03-22	Bunama tedavisi ve/veya profilaksisi i�in form�lasyon.
NO940093L (no)	1994-03-08	Cholecystokinin-antagonister anvendelige ved behandling av panikk-angrep
CA2222552A1 (en)	1996-12-05	N-oxides as antibacterial agents
EP0319073A3 (en)	1990-12-19	Cyclo-octane neuroprotective agents
SI0786998T1 (en)	2003-04-30	Use of r-(z))-alpha-(methoxyimino)-alpha-(1-azabicyclo 2.2.2) oct-3-yl) acetonitrile to reduce amyloid beta a4 formation in alzheimer's disease

Legal Events

Date	Code	Title	Description
2010-04-15	RER	Ceased as to paragraph 5 lit. 3 law introducing patent treaties